HEXABODY
LIVE

Serial Number

79124376

Owner

Genmab A/S

Attorney

Max Vern

Filing Date

Nov 15, 2012

Add to watchlist:

No watchlists yet
View on USPTO

HEXABODY Trademark

Serial Number: 79124376 • Registration: 4496618

HEXABODY is a trademark filed by Genmab A/S on November 15, 2012. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

Genmab A/S (42 trademarks)

Carl Jacobsens Vej 30

Entity Type: 98

Genmab B.V. (4 trademarks)

Uppsalalaan 15

Entity Type: 16

Trademark Details

Filing Date

November 15, 2012

Registration Date

March 18, 2014

Published for Opposition

December 31, 2013

Goods & Services

Medical, scientific and biological research; [ medical, scientific and biological ] research in [ the field of ] antibodies, bi and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies, bi and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these; chemical analysis [ ; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy; development of pharmaceuticals containing antibodies, bi and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these ]

Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, bi and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases

Legal services in the form of patent exploitation, namely, patent consultation, patent licensing, and providing information about patent rights; licensing of intellectual property in the field of medicine

Chemical, biochemical, biological, and biotechnological, preparations, namely, antibodies, bi- and multispecific antibodies as well as fragments, monovalent antibodies, derivatives of conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 25, 2025 INPR
NEW REPRESENTATIVE AT IB RECEIVED
Apr 24, 2025 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Feb 25, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Feb 25, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 24, 2025 APRE
TEAS SECTION 71 RECEIVED
Sep 16, 2024 ES71
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 5, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 5, 2024 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Jun 5, 2024 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 5, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 5, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 5, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 5, 2024 COAR
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Mar 18, 2023 REM4
INTERNATIONAL REGISTRATION RENEWED
Dec 2, 2022 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Sep 25, 2021 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Aug 3, 2021 INPS
INVALIDATION PROCESSED
Aug 3, 2021 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 24, 2021 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Nov 24, 2020 NA71
REGISTERED-SEC.71 ACCEPTED
Nov 24, 2020 71AG
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Nov 2, 2020 EROP
POST REGISTRATION ACTION MAILED - SEC.71
May 1, 2020 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 30, 2020 APRE
TEAS SECTION 71 RECEIVED
Mar 17, 2020 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 18, 2019 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 14, 2018 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Sep 8, 2017 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Apr 20, 2017 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 9, 2017 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 12, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 20, 2014 FICS
FINAL DISPOSITION PROCESSED
Jun 20, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 18, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 18, 2014 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2013 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2013 PUBO
NOTIFICATION PROCESSED BY IB
Dec 30, 2013 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 11, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 11, 2013 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 11, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 22, 2013 PREV
ASSIGNED TO LIE
Nov 22, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 1, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 18, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 18, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 18, 2013 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 18, 2013 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 20, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 20, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 20, 2013 TROA
REFUSAL PROCESSED BY IB
May 6, 2013 RFNP
CHANGE OF OWNER RECEIVED FROM IB
Apr 19, 2013 CHLD
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 20, 2013 RFCS
REFUSAL PROCESSED BY MPU
Mar 20, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 20, 2013 RFCR
NON-FINAL ACTION WRITTEN
Mar 19, 2013 CNRT
ASSIGNED TO EXAMINER
Mar 12, 2013 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 8, 2013 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 4, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 31, 2013 REPR